ERBB2 and in situ carcinoma: The current role of early cystectomy in CIS is controversial, some altered gene expression as high mRNA expression of ERBB2 is suggested to be useful to identify a high-risk group for progression who will benefit from an early cystectomy (13), although the potential for overtreatment must also be considered.